Swot Analysis Of Univar

Company Overview
Univar is a world leader in distribution of industrial, specialty chemical and related products and services. The Company offers also offers products like solvents, resins, pigments, acids, bases, surfactants, glycols, inorganic compounds to industries such as coatings and adhesives, food, oil and gas, personal care, and pharmaceutical all across the globe. Univar is more than just a distribution company; they are a global partner to customers and suppliers to earning customers for life, creating enduring supplier relationship and providing an innovative suite of value added services.
We safely deliver chemistry (products, expertise, and relationships) that helps our customers improve the quality of life through:
• Affordable

chemical distributor at about $3.03 billion with shares closing at $25.4, premium of 15.5%, at the end of the first day of trading. The company expected the IPO to be priced between $20 and $22 per share and offered a total of 35 million shares. The deal size was 83% larger than originally proposed after it priced at the high end while CVC Capital added 15 million shares (43% of the total). It also raised as much as $500 million from Temasek in a private placement.
Recently, the shares touched a 52 week high of $29.81/share gaining over 179.91% or $19.16/share from a 52 week low of $10.65/share attained on 02/11/2016. Also, Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely.
Underwriters

Deutsche Bank Securities, Goldman Sachs & co, and BofA Merrill Lynch acted as joint book running managers. Additional book-running managers included Barclays Capital Inc., Credit Suisse Securities(USA) LLC, J.P Morhan Securities LLC, Jefferies LLC, and Morgan Stanley & Co. LLC. The offering was made only by means of a prospectus.
Use of

and certain other of our stockholders to the Temasek Investor.
• Estimated net proceeds that we will receive from this offering is approximately $407.6 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by us is approximately $32.4 million in connection with this offering. The estimated net proceeds that we will receive from the sale of 17,636,684 shares of our common stock in the concurrent private placement will be approximately $350.0 million.
• Interest on the 2017 Subordinated Notes and the 2018 Subordinated Notes is payable in arrears quarterly at the rate of 10.50% per annum payable quarterly to holders of record as of the record date immediately preceding the interest payment date. The 2017 Subordinated Notes mature on September 30, 2017 and the 2018 Subordinated Notes mature on June 30,